Bausch Health Companies (BHC) Total Non-Current Liabilities (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Total Non-Current Liabilities came in at $24.8 billion in Q1 2026, down 4.18% year-on-year from $25.9 billion in Q1 2025, and down 1.5% quarter-over-quarter from $25.2 billion in Q4 2025.

Bausch Health Companies (BHC) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $24.8 billion for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $24.8 billion, down 4.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.8 billion (down 4.18% YoY), and the FY2025 annual result was $25.2 billion, down 3.58% from the prior year.
  • Total Non-Current Liabilities came in at $24.8 billion for Q1 2026 at Bausch Health Companies, down from $25.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $28.7 billion in Q1 2022 to a low of $24.5 billion in Q2 2023.
  • The 5-year median for Total Non-Current Liabilities is $26.0 billion (2024), against an average of $25.9 billion.
  • Peak annual rise in Total Non-Current Liabilities reached 7.98% in 2023, while the deepest fall reached 14.41% in 2023.
  • Bausch Health Companies' Total Non-Current Liabilities stood at $24.7 billion in 2022, then rose by 7.98% to $26.7 billion in 2023, then slipped by 1.97% to $26.1 billion in 2024, then dropped by 3.58% to $25.2 billion in 2025, then decreased by 1.5% to $24.8 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $24.8 billion (Q1 2026), $25.2 billion (Q4 2025), and $25.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn 24.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.82 Bn
Dec 31, 2025 25.20 Bn
Sep 30, 2025 25.63 Bn
Jun 30, 2025 26.24 Bn
Mar 31, 2025 25.90 Bn
Dec 31, 2024 26.13 Bn
Sep 30, 2024 25.98 Bn
Jun 30, 2024 25.98 Bn
Mar 31, 2024 26.34 Bn
Dec 31, 2023 26.66 Bn
Sep 30, 2023 26.58 Bn
Jun 30, 2023 24.49 Bn
Mar 31, 2023 24.55 Bn
Dec 31, 2022 24.69 Bn
Sep 30, 2022 25.25 Bn
Jun 30, 2022 27.39 Bn
Mar 31, 2022 28.69 Bn
Dec 31, 2021 28.58 Bn
Sep 30, 2021 28.52 Bn
Jun 30, 2021 29.68 Bn